← Back to Clinical Trials
Recruiting NCT06824337

NCT06824337 Effect of Targeted Mobilization Program

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06824337
Status Recruiting
Phase
Sponsor Nigde Omer Halisdemir University
Condition Caesarean Section
Study Type INTERVENTIONAL
Enrollment 64 participants
Start Date 2024-12-01
Primary Completion 2025-03-01

Eligibility & Interventions

Sex Female only
Min Age 18 Months
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
mobilization training and targeted mobilization

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 64 participants in total. It began in 2024-12-01 with a primary completion date of 2025-03-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study was planned to evaluate the effect of early mobilization training given to patients undergoing cesarean section in the preoperative period and targeted mobilization program applied after the surgery, on preventing gastrointestinal complications that may develop after the surgical intervention and participating in breastfeeding and baby care. The research will be conducted in experimental design. The research will begin after receiving written permission from Niğde Ömer Halisdemir University Ethics Committee, Niğde Provincial Health Directorate and Ömer Halisdemir Training and Research Hospital. Pregnant women who are between the ages of 18-35, who are at least a primary school graduate, who gave birth at term, who have a live singleton pregnancy, and who do not have a risky pregnancy history (DVT, thromboembolism) will be included in the study. Before starting the research, the study will begin by obtaining institutional permissions and written permission from the pregnant women. Personal Information Form prepared in line with the literature, postoperative gastrointestinal functions information form, postoperative abdominal distension diagnosis form, walking chart, VAS, LATCH Breastfeeding Diagnosis and Evaluation Scale and Breastfeeding Information Form data collection forms will be used to collect data. The data will be evaluated on a computer using the IBM SPSS Statistics 24 (Statistical Package for the Social Sciences for Windows) package program. Appropriate statistical analyzes will be used to evaluate the data

Eligibility Criteria

Inclusion Criteria: * Between the ages of 18-35, * At least primary school graduate, * Giving birth at term * Having a live singleton pregnancy, * No risky pregnancy history (DVT, thromboembolism) * Women who can use a mobile phone Exclusion Criteria: * Exclusion Criteria for the Study * Those who want to leave the study, * Undergoing emergency caesarean section, * Not recording walking distance * Women who cannot be interviewed within 24 hours of discharge * Women who develop maternal or neonatal complications after birth

Contact & Investigator

Central Contact

BİRNUR YEŞİLDAĞ, DR.

✉ nurumbirnur@gmail.com

📞 +90 05336815923

Principal Investigator

isa temur, Dr

PRINCIPAL INVESTIGATOR

NİĞDE ÖMER HALİSDEMİR UNIVERCITY

Frequently Asked Questions

Who can join the NCT06824337 clinical trial?

This trial is open to female participants only, aged 18 Months or older, up to 35 Years, studying Caesarean Section. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06824337 currently recruiting?

Yes, NCT06824337 is actively recruiting participants. Contact the research team at nurumbirnur@gmail.com for enrollment information.

Where is the NCT06824337 trial being conducted?

This trial is being conducted at Niğde, Turkey (Türkiye).

Who is sponsoring the NCT06824337 clinical trial?

NCT06824337 is sponsored by Nigde Omer Halisdemir University. The principal investigator is isa temur, Dr at NİĞDE ÖMER HALİSDEMİR UNIVERCITY. The trial plans to enroll 64 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology